True Wealth Design’s Foghorn Therapeutics FHTX Stock Holding History

True Wealth Design’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$69	Sell	14 -6	-30%	-$27	﹤0.01%	2577
2026 Q1	$96	Buy	20 +15	+300%	+$82	﹤0.01%	2476
2025 Q4	$27	Sell	5 -6	-55%	-$27	﹤0.01%	2464
2025 Q3	$54	Hold	11	–	–	﹤0.01%	2559
2025 Q2	$52	Sell	11 -70	-86%	-$293	﹤0.01%	2370
2025 Q1	$296	Buy	+81	New	+$369	﹤0.01%	1782

Other funds holding FHTX

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

True Wealth Design's FHTX Position: Q2 2026 in Review

True Wealth Design reduced its Foghorn Therapeutics (FHTX) stake by 30% in Q2 2026, selling an estimated $27 and leaving 14 shares worth $69. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

True Wealth Design first reported a position in FHTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $296 in Q1 2025. 4 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

True Wealth Design held 14 shares of Foghorn Therapeutics worth $69 as of Q2 2026.
True Wealth Design sold 6 Foghorn Therapeutics shares in Q2 2026, an estimated $27.
Foghorn Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2577 holding.
True Wealth Design first reported a position in Foghorn Therapeutics in Q1 2025 and has held it in 6 quarters since.
True Wealth Design's Foghorn Therapeutics position peaked at $296 in Q1 2025.
4 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.